COVID-19 update: Sept. 3, 2020
Special public comment proposal and OPO testing of deceased donors ensures patient safety
Scientists find evidence of recipient factor in predicting donor ESRD
UNOS researchers studied post-donation end-stage renal disease in white first-degree related living kidney donors in the U.S. between 1994 and 2018. The study is the first of its kind to adjust for recipient factors.
Changes to unacceptable antigens in KPD and Waitlist
Effective Sept. 2, KPD and Waitlist users who enter unacceptable antigens will have the ability to select antigen 16:01 for locus DPB1.
VCA programs to reapply to OPTN ahead of upcoming changes to bylaws and policy
Programs to have 120 days to submit applications, application release date being finalized.
New initiatives support transplant hospitals, OPOs and patients
Three new OPTN-funded IT projects are underway at UNOS.
In Memoriam: G. Melville Williams, M.D.
In Memoriam – G. Melville Williams, M.D. The life and legacy of a pioneer in transplant and the founding president of UNOS.
Special public comment period begins Aug. 31 for proposed COVID-related lung diagnoses
To help track future transplant candidates, the OPTN Lung Transplantation Committee proposes to establish diagnoses for acute respiratory distress syndrome (ARDS) and pulmonary fibrosis relating to COVID-19.
COVID-19 updates: Aug. 28, 2020
Special public comment proposal. Site surveys and OPTN committee meetings to be held virtually through Oct. 31. Plus, top COVID resources and webinars.
OPO testing of deceased donors for COVID-19 ensures patient safety
Recent report shows 100 percent COVID-19 donor testing by OPOs.
Phase II of the offer filters project launches on Aug. 27
UNOS will pilot phase II of a project that allows kidney transplant programs to bypass single kidney donor offers they do not want to receive using filters.